Pain · 2011 · 197 citations · 48 references
MedicinePharmacotherapyTemporomandibular DisordersOrofacial PainPain ManagementPain MedicineAnalgesiaBotulinum Toxin TherapyBotulinum Toxin TreatmentBotulinum NeurotoxinBotulinum Toxin DosageBotulinum ToxinsIntradetrusor Botulinum Toxin InjectionIntradetrusor Botulinum Toxin TherapyIsotonic Saline TherapyNeurotoxin InjectionsTemporomandibular Disorder Pain Management
Evidence of an effect by botulinum toxins is still lacking for most pain conditions. In the present randomized, placebo-controlled, crossover multicenter study, the efficacy of botulinum toxin type A (BTX-A) was investigated in patients with persistent myofascial temporomandibular disorders (TMD). Twenty-one patients with myofascial TMD without adequate pain relief after conventional treatment participated. A total of 50 U of BTX-A or isotonic saline (control) was randomly injected into 3 standardized sites of the painful masseter muscles. Follow-up was performed after 1 and 3 months, followed by a 1-month washout period, after which crossover occurred. Pain intensity at rest was the primary outcome measure, while physical and emotional function, global improvement, side effects, and clinical measures were additional outcome measures. There was no main difference between drugs (ANOVA; P=.163), but there was a significant time effect (P<.001), so BTX-A reduced mean (SD) percent change of pain intensity by 30 (33%) after 1 month and by 23 (30%) after 3 months compared to 11 (40%) and 4 (33%) for saline. The number of patients who received a 30% pain reduction was not significantly larger for BTX-A than after saline at any follow-up visit. The number needed to treat was 11 after 1 month and 7 after 3 months. There were no significant changes after treatment in any other outcome measures, with the exception of pain on palpation, which decreased 3 months after saline injection (P<.05). These results do not indicate a clinical relevant effect of BTX-A in patients with persistent myofascial TMD pain.
48
The validation of visual analogue scales as ratio scale measures for chronic and experimental pain
Donald D. Price, Patricia McGrath, Amir Rafii et al. · Pain · 1983 · 3.9K citations
Nursing, Psychology, Pain Medicine +16
Defining the clinically important difference in pain outcome measures
John T. Farrar, Russell K. Portenoy, Jesse A. Berlin et al. · Pain · 2000 · 1.1K citations